A
ATOS
Atossa Therapeutics Inc
0.78
0.01+0.94%Opening14:44 08/18 EDT
OPEN/PREV CLOSE0.7725/0.7765
TODAY RANGE0.7725-0.7993
VOL387.22K
MARKET CAP101.24M
52 WEEK RANGE0.5526-1.660
AVG VOL (3M)1.16M
% TURNOVER0.30%
TURNOVER--
P/E (TTM)-3.4867
% RANGE3.45%
EPS(TTM)-0.2248
P/E(FORWARD)-3.1992
P/B1.755
BVPS0.4467
DIVIDEND--
P/S0.3716
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP101.17M
SHARES OUTSTANDING129.17M
NEXT EARNINGS11/10-11/14
FREE FLOAT129.08M
LOT SIZE1
EX-DATE04/20/2018
News
Press Releases
Financial Reports
Profile
TipRanks·5d ago
Atossa Therapeutics Advances Breast Cancer Treatments
Seeking Alpha·6d ago
Atossa Therapeutics GAAP EPS of -$0.07 misses by $0.01
Reuters·6d ago
ATOSSA THERAPEUTICS Q2 PRETAX PROFIT USD -8.423 MILLION
Dow Jones·6d ago
*Atossa Therapeutics 2Q Loss/Shr 7c >ATOS
Dow Jones·6d ago
Press Release: Atossa Therapeutics Announces -3-
TipRanks·07/30 13:45
Craig-Hallum Reaffirms Their Buy Rating on Atossa Therapeutics (ATOS)
TipRanks·07/29 11:50
Atossa Therapeutics reports ‘positive’ FDA feedback regarding (Z)-endoxifen
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.